Yahoo Web Search

Search results

  1. Jerry McMahon has over 30 years of biotechnology leadership, scientific innovation, deal-making, and financing experience. With broad disease-area expertise and a specialty in oncology therapeutics, he has held scientific, pharmaceutical, and venture capital positions, as well as CEO or president positions in multiple biotechnology companies ...

  2. Jerry McMahon, PhD Chief Executive Officer & President Jerry has over 30 years of biotechnology leadership, scientific innovation, creative deal-making, and financing experience.

  3. Oct 26, 2021 · Eastland will succeed Jerry McMahon, Ph.D., who has resigned from his position as President and Chief Executive Officer and as a member of the company’s Board of Directors (the “Board”). Dr....

  4. Oct 26, 2021 · Jerry McMahon, Ph.D., Resigns from Harpoon as President and Chief Executive Officer. Scott Myers, Current Member of Harpoon’s Board of Directors Named Chair, Replacing Ron Hunt Who...

    • Harpoon Therapeutics
  5. Sep 7, 2022 · 7 September 2022, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board Director.

  6. Nov 23, 2022 · Dr Jerry McMahon, CEO of STORM Therapeutics, said: “This is a major milestone for STORM as we enter clinical development with our lead candidate STC-15 and continue progressing a pipeline targeting RNA modifying enzymes beyond METTL3.

  7. People also ask

  8. As announced by Harpoon Therapeutics Inc. in a news release and in a regulatory filing published on Tuesday, October 26, 2021, Gerald (Jerry) McMahon leaves his post as chief executive officer at the clinical-stage immunotherapy company, after about five years in the role, effective immediately.

  1. People also search for